Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

DRUG(1)
1 unique interventions1 categories

Analytics

Trial Phases

Phase 31

Trial Status

Other1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT01844986Phase 3Active Not Recruiting
Olaparib Maintenance Monotherapy in Patients With BRCA Mutated Ovarian Cancer Following First Line Platinum Based Chemotherapy.
Advanced Ovarian CancerBRCA MutationComplete Response+4 more
PrincipalinvestigatorStart date: 2013-08-26

Research Network

Collaboration Network

2 collaborators·1 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Prof Kathleen Moore, MD

University of Oklahoma Health Sciences Center, Oklahoma City, USA

Very Similar
1 trials

Shared therapeutic areas:

Advanced Ovarian CancerBRCA Mutated Advanced (FIGO Stage III-IV) Ovarian CancerBRCA Mutation+5 more

Worked with same sponsors:

AstraZenecaGOG Foundation+2 more
Collaborated on 1 trial
Similarity Score84%

Jianping Weng, Doctor

Third Affiliated Hospital, Sun Yat-Sen University

Related
2 trials

Shared therapeutic areas:

Newly Diagnosed
Similarity Score4%

Giorgio Senaldi, MD, PhD

Daiichi Sankyo

Related
1 trials

Shared therapeutic areas:

Advanced Ovarian Cancer
Similarity Score4%

Sahar Salehi, MD, PhD

Karolinska Institute and Karolinska University Hospital

Related
1 trials

Shared therapeutic areas:

Advanced Ovarian Cancer
Similarity Score4%

Philipp Harter

European Network of Gynaecological Oncological Trial Groups (ENGOT)

Related
1 trials

Shared therapeutic areas:

Advanced Ovarian Cancer

Worked with same sponsors:

AstraZenecaGOG Foundation+1 more
Similarity Score4%

Jane Robertson, BSc, MBCHB, MD

AstraZeneca

Related
12 trials

Shared therapeutic areas:

Advanced Ovarian Cancer

Worked with same sponsors:

AstraZeneca
Similarity Score4%

Cyril Salek, MD

Institute of Hematology and Blood Transfusion, Czech Republic

Related
2 trials

Shared therapeutic areas:

Newly Diagnosed
Similarity Score4%

H.W.M. van Laarhoven, Md PhD

Radboud University Medical Center

Related
1 trials

Shared therapeutic areas:

BRCA Mutation
Similarity Score4%

TONG Zhongsheng

Professor of Medicine

Related
1 trials

Shared therapeutic areas:

BRCA Mutation
Similarity Score4%

hisham abo taleb, lecturer

Assiut University

Related
1 trials

Shared therapeutic areas:

Advanced Ovarian Cancer
Similarity Score4%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT01844986Phase 3PrincipalInvestigator

Olaparib Maintenance Monotherapy in Patients With BRCA Mutated Ovarian Cancer Following First Line Platinum Based Chemotherapy.

Advanced Ovarian CancerBRCA MutationComplete Response+4 more
Active Not Recruiting

All 1 trials loaded